Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Mona Robbins, PhD
Patient Support Professional Associate Professor
UT Southwestern
Comprehensive Adult Sickle Cell
2201 Inwood Road
3rd Floor, Suite 500
Dallas, Texas, United States
Dr. Mona Robbins is an Associate Professor in the Department of Psychiatry and the Licensed Psychologist for the UT Southwestern Comprehensive Adult Sickle Cell Disease Program. Her expertise is based in an undergraduate degree in Psychology from Howard University and a doctoral degree in Clinical/Community Psychology from the University of Illinois at Urbana-Champaign. Her additional post-doctoral fellowship in Pediatric Psychology at Children’s Medical Center of Dallas has aided in her developmental understanding of psychological factors that impact medical condition management.
Dr. Robbins developed a program of Psychological Services for adult patients with sickle cell disease from the transition point of young to later adulthood. Health and behavior evaluations and interventions are provided across both outpatient and inpatient settings with a focus on a variety of dynamics that impact functioning and health promotion such as:
– Adherence to Medical Regimen
– Coping Skill Development
– Mental Health Wellness
– Pain and Stress Management
– Premature Mortality
– Quality of Life Enhancement
– Sociocultural Influences
+myBinderRelated Content
-
Red Cell Pain Management Service at St George’s HospitalPeople with sickle cell disease can ofte...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Spencer Wood, MSSpencer Wood is a certified genetic coun...
-
Marilyn Telen, MDDr. Telen is the Associate Professor of ...
-
Foundation for Women & Girls with Blood DisordersIn 2010, the Foundation for Women & ...
-
Sickle cell disease: Information for physicians and other health care professionalsSickle cell disease is a term for hemogl...
-
Sancilio Pharmaceuticals Company, Inc. (SPCI) Receives Rare Pediatric Disease Designation From the US Food and Drug ...Sancilio Pharmaceuticals Company, Inc. (...
